LAIR1 and glioma: Our results imply that, at least in glioma cells, LAIR1-induced FAK nuclear translocation has a greater effect on malignant glioma growth than FAK catalytic activity inhibition, emphasizing the importance of assessing LAIR1 expression levels when utilizing FAK inhibitors for cancer treatment.